WHO ICTRP trial

Efficacy and safety of oliceridine for postoperative patient-controlled…

ChiCTR2400090780 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting

Key facts

Trial ID ChiCTR2400090780
Public title Efficacy and safety of oliceridine for postoperative patient-controlled intravenous analgesia in elderly patients undergoing laparoscopic radical resection of gastrointestinal tumors: a non-inferiority study
Scientific title Efficacy and safety of oliceridine for postoperative patient-controlled intravenous analgesia in elderly patients undergoing laparoscopic radical resection of gastrointestinal tumors: a non-inferiority study
Primary sponsor Tangdu Hospital, Air Force Medical University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Recruiting
Study type Interventional study
Phase 4
Countries China
Conditions gastrointestinal tumor
Interventions Oliceridine group (Group O):PCIA with oliceridine;Sufentanil group (Group S):PCIA with sufentanil
Registration date Oct 13, 2024
Target size Oliceridine group (Group O):45;Sufentanil group (Group S):45
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations